Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)

Tobacco smoking is recognized as a global pandemic resulting in 6 million deaths per year. Despite a variety of anti-smoking products available to aid with tobacco cessation, the majority of people who attempt to quit smoking relapse within 6 months due to the addictive nature of nicotine. An immuno...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Heliyon
Autori principali: Fraleigh, Nya L., Boudreau, Justin, Bhardwaj, Nitin, Eng, Nelson F., Murad, Yanal, Lafrenie, Robert, Acevedo, Reinaldo, Oliva, Reynaldo, Diaz-Mitoma, Francisco, Le, Hoang-Thanh
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008958/
https://ncbi.nlm.nih.gov/pubmed/27622215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2016.e00147
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi